Is red light therapy safe after breast cancer?
October 25
It sounds like you're looking for information about lobular breast cancer — a great topic to understand more deeply!
Lobular breast cancer starts in the lobules, which are the milk-producing glands in the breast. There are two main forms:
- Lobular Carcinoma In Situ (LCIS): The cells are abnormal but not truly cancerous Show Full Answer
It sounds like you're looking for information about lobular breast cancer — a great topic to understand more deeply!
Lobular breast cancer starts in the lobules, which are the milk-producing glands in the breast. There are two main forms:
- Lobular Carcinoma In Situ (LCIS): The cells are abnormal but not truly cancerous. However, having LCIS does raise the risk of developing invasive breast cancer later.
- Invasive Lobular Carcinoma (ILC): This is when cancer cells have spread beyond the lobules into surrounding breast tissue. It's the second most common type of breast cancer in the U.S. One important thing to know about ILC is that it can be harder to detect early, and is more likely to be diagnosed at a later stage compared to other types.
When it comes to receptors, most ILC tumors are:
- ER-positive (estrogen receptor-positive) — about 95%
- PR-positive (progesterone receptor-positive) — about 70%
- HER2-positive cases are rare with ILC
Because most ILC is hormone receptor-positive, hormone-blocking treatments like Tamoxifen are commonly used as part of the treatment plan. Prognosis largely depends on the stage at diagnosis, so early detection and open conversations with your oncology team are really important. Don't hesitate to ask your doctor about your specific receptor status and what treatment options make the most sense for you.
October 25
Join
Your Privacy Choices
